Buradasınız

Study of smoking Index, spirometry and severity of chronic lung disease

Journal Name:

Publication Year:

Abstract (2. Language): 
Introduction: It has been estimated that there are 45 million Asthma and COPD sufferers in India and this number is expected to increase to 57.2 million over the next decade according to National Centre for Macroeconomics and Health, Government of India. With this in mind present study was planned to study correlation between severity of smoking and lung diseases. Methodology: 100 patients having respiratory complaints were selected randomly from OPD and were screened for various respiratory disorders ( COPD ,Asthma ,ILD, Bronchiectasis, Post-infectious fibrosis, & Occupational lung diseases) by symptomatology, history, clinical examination, Chest X ray & spirometry.( Standard criteria were used for diagnosis of various respiratory disorders).The youngest was 20 yrs and the oldest was 65 years, mean age being 41 years. 64% were males and 36% were females. Dyspnea grading as per MMRC Scale showed 39% had grade I ,36% grade II and 11% grade III dyspnea. Results: Using Correlation co-efficient test, highly significant inverse correlation was found between MMRC scale of dyspnea and FEV1%, i.e. as the scale of dyspnea increases, the FEV1 decreases. Using Correlation co-efficient test, highly significant inverse correlation was found between Smoking Index in pack years and FEV1%., i.e. as the Smoking index increases, the FEV1 decreases.
FULL TEXT (PDF): 
1043-1046

REFERENCES

References: 

1) Murthy KJR .NCMH Background papers – Burden of Diseases in India – 2005.
2) Nongkynrih et al . Journal of association of Physicians of India , Feb 2004; 52 : 118-123.
3) Pellegrino R, Viegi G, Enright P et al. Interpretative strategies for lung function tests. Eur Respir J 2005; 26: 948-968.
4) Donald A Redelmeier, Roger S, Simon T, Robert H. Spirometry and Dyspnea in patients with COPD. When small
differences mean little. CHEST 1996; 109; 1163-8.
5) Safwat T, Wagih K, et al. Correlation between Forced expiratory volume in first second (FEV1) and diffusing capacity of
the lung for carbon monoxide (DLCO) in chronic obstructive pulmonary disease. EJB; Vol 3,No 2, 119-123,Dec 2009.
6) Targowski T, Jahnz-Rózyk K, From S, Płusa T. Relationship between disease severity, smoking index age and direct costs
of hospital treatment of COPD exacerbations. Pneumonol Alergol Pol. 2005;73(1):32-5.
7) FEV1 % and FEV1/FVC % in smokers with special reference to Chronic Obstructive Pulmonary
DiseasesShivanand K G, Manjunath M L, Shirahatti K Das.International Journal of Biomedical Research: Vol
3:No.10:2012.

Thank you for copying data from http://www.arastirmax.com